Stryker (SYK) Revenue Growth (3y) (2012 - 2026)
Stryker (SYK) Revenue Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 17.14% |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 2.92% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | 0.73% |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | 7.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.01% |
| Dec 31, 2025 | 11.29% |
| Sep 30, 2025 | 10.58% |
| Jun 30, 2025 | 10.26% |
| Mar 31, 2025 | 11.12% |
| Dec 31, 2024 | 11.04% |
| Sep 30, 2024 | 9.71% |
| Jun 30, 2024 | 8.09% |
| Mar 31, 2024 | 9.87% |
| Dec 31, 2023 | 10.91% |
| Sep 30, 2023 | 9.52% |
| Jun 30, 2023 | 21.81% |
| Mar 31, 2023 | 10.02% |
| Dec 31, 2022 | 7.99% |
| Sep 30, 2022 | 7.68% |
| Jun 30, 2022 | 7.17% |
| Mar 31, 2022 | 6.73% |
| Dec 31, 2021 | 7.39% |
| Sep 30, 2021 | 8.67% |
| Jun 30, 2021 | 8.93% |